Call Now Book Consultation
Total vs Free Testosterone

Total vs Free Testosterone: Why Total T Alone Is Misleading

A man goes to his doctor with every symptom of low testosterone: fatigue, low drive, soft physique despite training, poor sleep, declining performance in the gym and the bedroom. The doctor orders a testosterone test. It comes back at 480 ng/dL, which falls in the “normal” range. The man is told his testosterone is fine and his symptoms must be something else. He leaves with no answers and the same symptoms he walked in with.

The problem is that the doctor measured the wrong number, or more precisely, only part of the number. Total testosterone, the value most primary care offices run, can look perfectly normal while the testosterone that actually does the work in your body sits well below where it should be. The missing piece is free testosterone, and the protein that explains the gap is one most standard panels never test.

The Three Forms of Testosterone in Your Blood

Testosterone does not float freely through your bloodstream as a single pool. It exists in three forms, and they are not equally useful to your body.

The first form is testosterone bound tightly to a protein called sex hormone binding globulin (SHBG). This fraction is locked up. It cannot enter cells and cannot activate the androgen receptor. It is effectively inactive, a reserve that is not currently doing anything.

The second form is testosterone bound loosely to albumin, another blood protein. This bond is weak enough that the testosterone can come free and become available to tissues when needed. This fraction is considered bioavailable.

The third form is free testosterone, which is not bound to anything. It is immediately available to enter cells and do its job. This is the most active fraction.

Total testosterone, the number on most lab reports, adds all three together. It counts the locked-up SHBG-bound fraction the same as the free and bioavailable fractions. That is the core of the problem. A high total testosterone number tells you nothing about how much of that testosterone is actually available to your body if a large portion is bound up and inactive.

Why Only Free and Bioavailable Testosterone Count

Your symptoms are driven by the testosterone that can actually reach and activate the androgen receptors in your muscles, brain, bone, and other tissues. That means the free fraction and the loosely bound bioavailable fraction. The tightly bound SHBG fraction contributes to your total number but does nothing for your symptoms.

This is why two men with the same total testosterone can feel completely different. If one man has most of his testosterone bound to SHBG and the other has a larger free fraction, the second man has far more biologically active testosterone despite an identical total reading. The total number hides the difference. The free number reveals it.

SHBG: The Variable That Explains the Gap

SHBG is the key to understanding why total testosterone can mislead. It is the protein that binds testosterone and takes it out of action. The amount of SHBG in your blood determines how much of your total testosterone ends up locked away versus available.

Several factors raise SHBG, which lowers your free testosterone even if your total stays the same. Aging itself tends to increase SHBG, which is part of why older men can have a normal total testosterone but low free testosterone. Hyperthyroidism raises it. Low insulin levels raise it. Certain medications raise it. So a lean, healthy, older man is a prime candidate for high SHBG dragging down his free testosterone while his total looks reassuring.

Other factors lower SHBG, which can keep free testosterone adequate even when total testosterone looks low. Insulin resistance lowers SHBG. Obesity lowers it. So a heavier, metabolically unhealthy man can have a low-looking total testosterone but a free fraction that is less deficient than the total suggests, because less of his testosterone is bound up.

SHBG is the hidden variable in nearly every confusing testosterone result. Without measuring it, you cannot interpret the total number with any confidence. We covered SHBG and the other markers that standard panels skip in the post on hormone labs most doctors skip.

How Free Testosterone Is Measured

There are two main ways to get a free testosterone value, and they are not equally reliable.

The gold standard is direct measurement by equilibrium dialysis. This is a specialized lab technique that physically separates the free fraction and measures it. It is accurate but more expensive and less commonly run, and some labs offer a less reliable direct immunoassay that should not be confused with true equilibrium dialysis.

The more common approach is calculated free testosterone. This uses a validated formula (the Vermeulen equation is the most widely used) that estimates free testosterone from three inputs: total testosterone, SHBG, and albumin. When all three are measured, the calculation is reasonably accurate and far cheaper than equilibrium dialysis. This is why a proper testosterone workup measures total testosterone, SHBG, and albumin together. With those three values, free testosterone can be calculated reliably.

The takeaway is that you cannot get an accurate free testosterone value without measuring SHBG. A lab panel that reports only total testosterone simply does not have the data to tell you what your free testosterone is.

The Reference Range Problem

Lab reference ranges for total testosterone are built from large populations of men, and those populations include men with widely varying SHBG levels and therefore widely varying free testosterone. So the “normal” range for total testosterone lumps together men who feel great and men who feel terrible. Falling inside that range tells you that you are statistically typical, not that your testosterone is adequate for you.

The Endocrine Society clinical practice guidelines emphasize that testosterone evaluation should account for the clinical picture and, in cases where total testosterone is borderline or where SHBG abnormalities are suspected, free testosterone should be assessed. The guidelines recognize that total testosterone alone is insufficient in many cases. The problem is that this nuance often does not make it into a 15-minute primary care visit, where the total number gets checked against the range and the conversation ends.

The Two Phenotypes That Get Missed

Two specific patterns illustrate why total testosterone alone fails so often.

The first is the high SHBG, low free testosterone, normal total testosterone phenotype. This is common in lean, older men. Their total testosterone looks fine, sometimes even good, but their SHBG is elevated, so a large fraction of that testosterone is bound and inactive. Their free testosterone is low, and they have every symptom to match. Because their total number looks normal, they get told they are fine. This man is the classic case of a missed diagnosis, and he is extremely common in the professional demographic. We explored the broader picture for this patient in the post on testosterone optimization for men over 40.

The second is the low SHBG, adequate free testosterone, low total testosterone phenotype. This is often seen in metabolically unhealthy men. Their total testosterone looks low, but their SHBG is also low, so a larger fraction of their testosterone is free. Their free testosterone may be less deficient than the total suggests. This man might be treated based on a low total number when the fuller picture is more nuanced, or his underlying metabolic dysfunction might be the more important target. Either way, the total number alone leads to the wrong conclusion.

What an Optimization Workup Looks Like

For a man with vague low testosterone symptoms, a proper evaluation does not stop at total testosterone. At Towsen Clinic, the workup measures total testosterone, free testosterone (calculated from SHBG and albumin, or measured directly when warranted), SHBG, estradiol using a sensitive assay, and the upstream signals LH and FSH, along with related markers. This panel reveals not just how much testosterone you have, but how much is actually available and why your levels are where they are.

The interpretation considers the full pattern and your symptoms together, rather than checking a single number against a population range. A man with a normal total testosterone, high SHBG, and low free testosterone has a clear and treatable problem that a total-only test would have missed entirely. The estradiol piece matters too, because testosterone therapy decisions depend on the testosterone-to-estrogen balance, which we cover in the post on estrogen in men on testosterone therapy.

Because testosterone status is part of a larger hormonal picture, the evaluation often connects to the broader hormone optimization program and is detailed on the testosterone replacement therapy page.

The Bottom Line

If you have been told your testosterone is “normal” based on a single total testosterone number while you continue to feel every symptom of low testosterone, the evaluation was incomplete. Total testosterone alone cannot tell you how much testosterone is actually working in your body. Free testosterone and SHBG can.

If your total testosterone came back normal but your symptoms have not gone anywhere, schedule a consultation and we will run the panel that shows the real picture rather than the partial one.

Table of Contents

Schedule your comprehensive consultation with Dr. Towsen

Our Latest Posts

Sermorelin vs Ipamorelin vs CJC-1295: Practical Differences
16Jul

Sermorelin vs Ipamorelin vs CJC-1295: Practical Differences

Sermorelin, ipamorelin, and CJC-1295 get lumped together, but they work through different mechanisms and suit different patients. Here is how the two growth hormone pathways work, why the peptides get combined, and which protocol fits which goal.

Tesamorelin for Visceral Fat: What the Clinical Data Shows
16Jul

Tesamorelin for Visceral Fat: What the Clinical Data Shows

Most growth hormone peptides have thin evidence for fat loss. Tesamorelin is the exception, FDA-approved with real trial data measuring visceral fat reduction by CT imaging. Here is how the mechanism works, who fits the protocol, and what monitoring it requires.

The FDA Peptide Crackdown: What Patients Need to Know in 2026
16Jul

The FDA Peptide Crackdown: What Patients Need to Know in 2026

The FDA did not simply ban peptides. It placed several in a restricted category, removed some in 2026, and scheduled a review for late July 2026 to decide what can be compounded. Here is the framework, the timeline, and what it means for patients.

HCG, Enclomiphene, TRT: Comparing Modern Testosterone Options
16Jul

HCG, Enclomiphene, TRT: Comparing Modern Testosterone Options

Testosterone injections are not the only answer to low T anymore. HCG, enclomiphene, and combination protocols can raise testosterone while preserving fertility and natural production. Here is how the modern options compare and which fits which situation.

Estradiol on TRT: Why Low E2 Is Worse Than Slightly High
16Jul

Estradiol on TRT: Why Low E2 Is Worse Than Slightly High

Testosterone forums push men to crush estrogen as low as possible. That advice causes joint pain, low libido, and bone loss. Men need estradiol for bone, joints, mood, and cardiovascular health. Here is what the right range actually looks like.

Total vs Free Testosterone: Why Total T Alone Is Misleading
02Jul

Total vs Free Testosterone: Why Total T Alone Is Misleading

Two men with the same total testosterone can feel completely different. The total number counts testosterone that is bound and inactive. Free testosterone and SHBG explain the gap, and they are what standard panels usually skip.

GLP-1 Plateau at Month 6: What Actually Causes It
01Jul

GLP-1 Plateau at Month 6: What Actually Causes It

Weight loss on semaglutide or tirzepatide slows around month six, and the trial curves predicted it. The plateau is the body’s energy conservation response, not drug failure. Here is the physiology and the clinical levers that push through it.

BMI Is Broken: Better Metrics for Body Composition After 40
30Jun

BMI Is Broken: Better Metrics for Body Composition After 40

BMI was built by an astronomer for population statistics, not patients. It cannot tell muscle from fat or measure where you store it. Here are the metrics that actually predict metabolic risk and how to track them at home or with a DEXA scan.

GLP-1 Muscle Loss: A Clinical Framework to Prevent It
30Jun

GLP-1 Muscle Loss: A Clinical Framework to Prevent It

Rapid weight loss on semaglutide or tirzepatide costs muscle if you do not plan for it. The trial data confirms the loss is real and largely preventable. Here is the protein, training, dose, and supplement framework that actually works.

TRT and Fertility: How to Treat Low T Without Losing Sperm Count
29Jun

TRT and Fertility: How to Treat Low T Without Losing Sperm Count

Standard testosterone therapy suppresses sperm production, sometimes to zero. But men do not have to choose between treating low testosterone and having children. Here are the fertility-friendly protocols, including HCG and enclomiphene, and how to evaluate them.

Microdosing GLP-1s: What the Clinical Evidence Actually Shows
22May

Microdosing GLP-1s: What the Clinical Evidence Actually Shows

Microdosing semaglutide and tirzepatide is an off-label trend with mixed evidence. The biology is plausible, but the clinical validation for microdoses specifically is thinner than the marketing suggests. Here is what the data actually shows.

Compounded vs Brand-Name Semaglutide in 2026: What Patients Should Actually Know
22May

Compounded vs Brand-Name Semaglutide in 2026: What Patients Should Actually Know

The FDA semaglutide shortage is over and compounding rules have changed. Some compounded forms remain available, others do not, and the source quality varies enormously. See what to ask before agreeing to either pathway in 2026.

Considered discovered ye sentiments projecting entreaties of melancholy.

Popular Procedures

Breast Augmentation

Mommy Makeover

Eyelid Surgery

Skin Care Treatment

Contact